| Updated results of PURE-01 with preliminary activity of neoadjuvant pembrolizumab in patients with muscle-invasive bladder carcinoma with variant histologies A Necchi, D Raggi, A Gallina, R Madison, M Colecchia, R Luciano, ... European urology 77 (4), 439-446, 2020 | 271 | 2020 |
| Development and internal validation of a novel model to identify the candidates for extended pelvic lymph node dissection in prostate cancer G Gandaglia, N Fossati, E Zaffuto, M Bandini, P Dell’Oglio, CA Bravi, ... European urology 72 (4), 632-640, 2017 | 216 | 2017 |
| Impact of molecular subtyping and immune infiltration on pathological response and outcome following neoadjuvant pembrolizumab in muscle-invasive bladder cancer A Necchi, D Raggi, A Gallina, JS Ross, E Farè, P Giannatempo, ... European urology 77 (6), 701-710, 2020 | 144 | 2020 |
| Radical prostatectomy in men with oligometastatic prostate cancer: results of a single-institution series with long-term follow-up G Gandaglia, N Fossati, A Stabile, M Bandini, P Rigatti, F Montorsi, ... European urology 72 (2), 289-292, 2017 | 117 | 2017 |
| Multiparametric magnetic resonance imaging as a noninvasive assessment of tumor response to neoadjuvant pembrolizumab in muscle-invasive bladder cancer: preliminary findings … A Necchi, M Bandini, G Calareso, D Raggi, F Pederzoli, E Farè, ... European urology 77 (5), 636-643, 2020 | 86 | 2020 |
| Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ M Bandini, EA Gibb, A Gallina, D Raggi, L Marandino, M Bianchi, JS Ross, ... Annals of Oncology 31 (12), 1755-1763, 2020 | 75 | 2020 |
| Early postoperative radiotherapy is associated with worse functional outcomes in patients with prostate cancer E Zaffuto, G Gandaglia, N Fossati, P Dell’Oglio, M Moschini, V Cucchiara, ... The Journal of urology 197 (3 Part 1), 669-675, 2017 | 74 | 2017 |
| Obesity and prostate cancer M Bandini, G Gandaglia, A Briganti Current Opinion in Urology 27 (5), 415-421, 2017 | 71 | 2017 |
| Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion F Preisser, M Bandini, M Marchioni, S Nazzani, Z Tian, RS Pompe, ... The Prostate 78 (6), 469-475, 2018 | 56 | 2018 |
| Survival after cytoreductive nephrectomy in metastatic non-clear cell renal cell carcinoma patients: a population-based study M Marchioni, M Bandini, F Preisser, Z Tian, A Kapoor, L Cindolo, ... European urology focus 5 (3), 488-496, 2019 | 55 | 2019 |
| A global approach to improving penile cancer care M Bandini, M Ahmed, G Basile, N Watkin, V Master, Y Zhu, G Prakash, ... Nature reviews Urology 19 (4), 231-239, 2022 | 51 | 2022 |
| Causal contributors to tissue stiffness and clinical relevance in urology L Martinez-Vidal, V Murdica, C Venegoni, F Pederzoli, M Bandini, ... Communications Biology 4 (1), 1011, 2021 | 50 | 2021 |
| Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy M Moschini, B Foerster, M Abufaraj, F Soria, T Seisen, M Roupret, P Colin, ... World Journal of Urology 35, 1541-1547, 2017 | 50 | 2017 |
| Local treatment for metastatic prostate cancer: a systematic review D Tilki, RS Pompe, M Bandini, M Marchioni, A Kretschmer, Z Tian, ... International Journal of Urology 25 (5), 390-403, 2018 | 47 | 2018 |
| Improved cancer-specific free survival and overall free survival in contemporary metastatic prostate cancer patients: a population-based study M Bandini, RS Pompe, M Marchioni, E Zaffuto, G Gandaglia, N Fossati, ... International urology and nephrology 50, 71-78, 2018 | 46 | 2018 |
| Predicting the pathologic complete response after neoadjuvant pembrolizumab in muscle-invasive bladder cancer M Bandini, JS Ross, D Raggi, A Gallina, M Colecchia, R Lucianò, ... JNCI: Journal of the National Cancer Institute 113 (1), 48-53, 2021 | 44 | 2021 |
| The impact of lymph node dissection and positive lymph nodes on cancer‐specific mortality in contemporary pT2‐3 non‐metastatic renal cell carcinoma treated … M Marchioni, M Bandini, RS Pompe, T Martel, Z Tian, SF Shariat, ... BJU international 121 (3), 383-392, 2018 | 43 | 2018 |
| Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial G Basile, M Bandini, EA Gibb, JS Ross, D Raggi, L Marandino, ... Clinical Cancer Research 28 (23), 5107-5114, 2022 | 42 | 2022 |
| Survival benefit of local versus no local treatment for metastatic prostate cancer—Impact of baseline PSA and metastatic substages RS Pompe, D Tilki, F Preisser, SR Leyh‐Bannurah, M Bandini, ... The Prostate 78 (10), 753-757, 2018 | 42 | 2018 |
| Association between human papillomavirus infection and outcome of perioperative nodal radiotherapy for penile carcinoma M Bandini, JS Ross, Y Zhu, DW Ye, AA Ornellas, N Watkin, BA Ayres, ... European Urology Oncology 4 (5), 802-810, 2021 | 40 | 2021 |
Alberto BrigantiVita-Salute San Raffaele University, Milan, ItalyVerified email at hsr.it
